Displaying 1 - 2 of 2
| Active Ingredient | ATOMOXETINE |
| Therapeutic Class | CENTRAL NERVOUS SYSTEM AGENTS, MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUMAZENIL |
| Therapeutic Class | CENTRAL NERVOUS SYSTEM AGENTS, MISCELLANEOUS |
| Indications | Reversal of benzodiazep ine-induced sedation. |
| Caution | Nausea, vomiting dizziness, increased sweating, pain at injection site, headache, and abnormal or blurred vision. |
| Dose Range |
200 microgramsadministered over 15 seconds, then 100 micrograms every 1 minute if required to a maximum total dose of 1 mg or occasionally 2 mg. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |